Many patients don’t understand electronic lab results

Article

A study from the University of Michigan found that many patients do not understand the significance of lab results that they receive electronically.

Ann Arbor, MI-A study from the University of Michigan found that many patients do not understand the significance of lab results that they receive electronically.

Patients are increasingly receiving test results outside of their doctor’s office as more doctors adopt electronic health records (EHR).

Doctors say EHR wastes time

The research team conducted an Internet survey asking more than 1,800 adults ages 40-70 to respond as though they had type 2 diabetes-nearly half of who did have the disease. The respondents were given displays showing test results for hemoglobin A1c as well as other blood tests. Participants were also given tests to measure their comprehension of numerical concepts and literacy skills.

According to researchers, people with low comprehension of numerical concepts and low literacy skills were less than half as likely to understand whether a lab result was inside or outside the reference ranges. As a result, they were also less able to use the results to decide whether or not they should call their doctor.

“We can spend all the money we want making sure that patients have access to their test results, but it won't matter if they don't know what to do with them,” says Brian Zikmund-Fisher, associate professor of health behavior and health education at the UM School of Public Health. “If we can design ways of presenting test results that make them intuitively meaningful, even for people with low numeracy and/or literacy skills, such data can help patients take active roles in managing their health care. In fact, improving how we show people their health data may be a simple but powerful way to improve health outcomes.”

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.